Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dormirin
- Development stage
- Unknown
- Lead developer
- PharmaS
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Dormirin is an orally administered over-the-counter dietary supplement from PharmaS used for sleep disturbance and sleep deprivation symptoms. Based on the provided product context, it is a consumer health sleep aid whose key active ingredient is melatonin; melatonin is intended to support sleep onset and circadian sleep signaling, while the overall Dormirin franchise may also include herbal components such as valerian and lemon balm in other product variants. The specific product queried here is best interpreted as the marketed Dormirin supplement brand rather than the stronger Dormirin FORTE or fast-acting Dormirin RAPID variants.
- Brand names
- Dormirin
02
Targets
MTNR1A (MT1)
Beyond the preview
Go deeper on Dormirin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dormirin.